arrow
B

Bshra A. Alsfouk

Al Azhar University
H指数:20
被引数:1,263

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Holistically benchmarked optimization-assisted green spectrophotometric–chemometric approach for simultaneous determination of piroxicam and venlafaxine in pharmaceutical formulations and spiked human plasma

综合基准化的优化辅助绿色分光光度法-化学计量学方法联用同时测定药物制剂和加标人血浆中吡罗昔康和文拉法辛

2026-09-250
OAAI
Exploring the Multifunctional Agents of Flavonoid-Rich Beet Leaf Extracts: Insights From Experimental and Computational Studies

探索黄酮类物质丰富的甜菜叶提取物中的多功能活性成分:来自实验和计算研究的见解

2025-10-010
OAAI
New 1,3,4-Thiadiazole-Based Dual B-Raf/VEGFR-2 Inhibitors With Potential Anti-Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations

新型1,3,4-噻二唑基双B-Raf/VEGFR-2抑制剂及其潜在抗乳腺癌活性:设计、合成、体外及计算机模拟评价

2025-09-280
PRE
Development of new thiadiazole-based compounds targeting VEGFR-2: In vitro anticancer evaluation, mechanistic investigations, and in silico studies

基于噻二唑的新化合物靶向VEGFR-2的开发:体外抗肿瘤评价、机制研究和计算机模拟研究

2025-08-090
PRE
Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activity

综合计算与生物学评价:具有靶向抗乳腺癌活性的新型噻二唑基VEGFR-2抑制剂的合成

2025-07-230
PRE
Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) Regimen

基于盐酸多柔比星和环磷酰胺(AC)方案化疗毒性的潜在风险,药代遗传学作为未来工具用于对乳腺癌患者进行风险分层。

2025-04-070
OA